NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Category: Ghostwriting

2 9/12/2017

Another ‘breach of trust’ at STAT: patient who praised TV drug ads says pharma PR company asked her to write op-ed

5 9/7/2017

‘A blow to [STAT’s] credibility’: MD listed as author of op-ed praising drug reps didn’t write it. Ghostwriting/PR influence

2 2/7/2013

David Healy’s depressing reflection on 25th anniversary of Prozac & SSRIs for depression

8 1/25/2013

Ghostwriting part 3: psych drug Paxil – and conclusion


Ghostwriting series part 2: Medtronic’s InFuse spinal fusion surgery product

8 1/23/2013

Introducing a three-part series on medical journal ghostwriting

2 12/22/2011

Pharma Ghosts Haunt New Hormone Research

2 12/6/2011

Guest post: Bring Health Writers Out of the Ghostwriting Shadows